Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baharak Babouee

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
BMC Infectious Diseases|April 29, 2014
Is switching to an oral antibiotic regimen safe after 2 weeks of intravenous treatment for primary bacterial vertebral osteomyelitis?Baharak Babouee Flury, Luigia Elzi, Marko Kolbe, et al.
Open Forum Infectious Diseases|January 29, 2020
Successful Treatment of Acute Prostatitis Caused by Multidrug-Resistant <i>Escherichia coli</i> With Tigecycline MonotherapyElia Lo Priore, David M Livermore, Niccolo Buetti, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 19, 2021
Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018Stefanie Barnsteiner, Florent Baty, Werner C Albrich, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2023
Cefepime Population Pharmacokinetics, Antibacterial Target Attainment, and Estimated Probability of Neurotoxicity in Critically Ill PatientsMuhammad Bilal, Michael Zoller, Uwe Fuhr, et al.
Praxis|February 18, 2025
[Helicobacter pylori]Fabian Egli, Dominik Dill, Baharak Babouee Flury, et al.
BMC Infectious Diseases|January 7, 2022
AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implicationsJulia Notter, Salome N Seiffert, Maria Zimmermann-Kogadeeva, et al.
Mbio|June 4, 2025
Multi-omics profiling of cross-resistance between ceftazidime-avibactam and meropenem identifies common and strain-specific mechanisms in <i>Pseudomonas aeruginosa</i> clinical isolatesBartosz J Bartmanski, Anja Bösch, Steven Schmitt, et al.
Antimicrobial Resistance and Infection Control|May 2, 2025
High rate of multi-drug resistant Escherichia coli isolated from patients with urinary tract infections in Ifakara-Tanzania: implications for empirical antibiotic treatment guidelines and stewardship programsMagreth Erick Macha, Philipp Kohler, Anja Bösch, et al.
Plos One|July 8, 2026
A novel design using a virtual control group to evaluate non-inferiority of nevirapine and lamivudine dual maintenance in HIV therapyAlessandro Suter, Markus Bickel, Carsten Depmeier, et al.
Antimicrobial Agents and Chemotherapy|February 10, 2016
Association of Novel Nonsynonymous Single Nucleotide Polymorphisms in ampD with Cephalosporin Resistance and Phylogenetic Variations in ampC, ampR, ompF, and ompC in Enterobacter cloacae Isolates That Are Highly Resistant to CarbapenemsBaharak Babouee Flury, Matthew J Ellington, Katie L Hopkins, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
BMC Infectious Diseases|April 29, 2014
Is switching to an oral antibiotic regimen safe after 2 weeks of intravenous treatment for primary bacterial vertebral osteomyelitis?Baharak Babouee Flury, Luigia Elzi, Marko Kolbe, et al.
Open Forum Infectious Diseases|January 29, 2020
Successful Treatment of Acute Prostatitis Caused by Multidrug-Resistant <i>Escherichia coli</i> With Tigecycline MonotherapyElia Lo Priore, David M Livermore, Niccolo Buetti, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 19, 2021
Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018Stefanie Barnsteiner, Florent Baty, Werner C Albrich, et al.
Antimicrobial Agents and Chemotherapy|June 27, 2023
Cefepime Population Pharmacokinetics, Antibacterial Target Attainment, and Estimated Probability of Neurotoxicity in Critically Ill PatientsMuhammad Bilal, Michael Zoller, Uwe Fuhr, et al.
Praxis|February 18, 2025
[Helicobacter pylori]Fabian Egli, Dominik Dill, Baharak Babouee Flury, et al.
BMC Infectious Diseases|January 7, 2022
AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implicationsJulia Notter, Salome N Seiffert, Maria Zimmermann-Kogadeeva, et al.
Mbio|June 4, 2025
Multi-omics profiling of cross-resistance between ceftazidime-avibactam and meropenem identifies common and strain-specific mechanisms in <i>Pseudomonas aeruginosa</i> clinical isolatesBartosz J Bartmanski, Anja Bösch, Steven Schmitt, et al.
Antimicrobial Resistance and Infection Control|May 2, 2025
High rate of multi-drug resistant Escherichia coli isolated from patients with urinary tract infections in Ifakara-Tanzania: implications for empirical antibiotic treatment guidelines and stewardship programsMagreth Erick Macha, Philipp Kohler, Anja Bösch, et al.
Plos One|July 8, 2026
A novel design using a virtual control group to evaluate non-inferiority of nevirapine and lamivudine dual maintenance in HIV therapyAlessandro Suter, Markus Bickel, Carsten Depmeier, et al.
Antimicrobial Agents and Chemotherapy|February 10, 2016
Association of Novel Nonsynonymous Single Nucleotide Polymorphisms in ampD with Cephalosporin Resistance and Phylogenetic Variations in ampC, ampR, ompF, and ompC in Enterobacter cloacae Isolates That Are Highly Resistant to CarbapenemsBaharak Babouee Flury, Matthew J Ellington, Katie L Hopkins, et al.
Pageof 4